Portman David J.
Reporting owner on Forms 3, 4 and 5, CIK 2126186.
- In the filer group Sermonix Pharmaceuticals, Inc.
Portman David J. reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-28.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| LONA · LeonaBio, Inc.CIK 1620463 | 10% owner | 1 | 2026-10-28 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| LONA · LeonaBio, Inc.Common Stock | 2026-10-26 | P bought | +3,149,470 | $3,149.47 | 3,149,470 | Form 4 |
| LONA · LeonaBio, Inc.Warrant, derivative | 2026-10-26 | P bought | -5,502,402 | $3,149.47 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002126186-26-000002 | LeonaBio, Inc. | 2026-10-28 | ||
| 13D/A 0001655566-26-000004 | LONA | 2026-10-28 |